11,826 Results

CHMP recommends Cosentyx for the treatment of adult patients with active non-radiographic axial spondyloarthritis. -Novartis

 Added 1 day ago

Novartis, announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

CHMP recommends Zolgensma for the treatment of patients with 5q spinal muscular atrophy . - Novartis

 Added 1 day ago

AveXis, a Novartis company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

CHMP recommends Zeposia to treat adult patients with relapsing remitting multiple sclerosis.- BMS

 Added 1 day ago

Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has...

Sanofi receives positive CHMP opinion for Sarclisa for the treatment of relapsed and refractory multiple myeloma.

 Added 1 day ago

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa (isatuximab)....

China’s National Medical Products Administration has accepted an application for the approval of denosumab copy biological HLX 14.- Shanghai Henlius Biotech

 Added 1 day ago

China’s National Medical Products Administration (NMPA), formerly the China Food and Drug Administration (CFDA), has accepted an application for the...

FDA accepts Genentech’s NDA for Xofluza for the treatment of influenza in children- Genentech/Roche

 Added 1 day ago

Genentech, a member of the Roche Group announced that the FDA has accepted a New Drug Application (NDA) as well...

EU gives CE mark approval to SARS-CoV-2 test for Coronavirus.- Thermo Fisher

 Added 2 days ago

Thermo Fisher Scientific Inc announced that it has received the CE mark in the European Union for its diagnostic test...

Interim analysis in phase III OVAL study of VB 111 shows positive outcome in ovarian cancer.- VBL Therapeutics

 Added 2 days ago

VBL Therapeutics announced an encouraging outcome of the planned interim analysis in the phase III OVAL study, a double-blind controlled...

Data from two Phase III trials in adult and pediatric patients for MM 36 showed statistically significant improvements in atopic dermatitis.- Medimetriks Pharmaceuticals

 Added 2 days ago

Medimetriks Pharmaceuticals announced that its partner, Otsuka Pharmaceuticals Co. Ltd., achieved positive results in two Phase III Japanese clinical trials...

Synairgen plc initiates Phase II trial of SNG 001 to treat COVID-19 patients .

 Added 2 days ago

Synairgen plc , the respiratory drug discovery and development company,announces that it has received expedited approvals from the Medicines and...

Load more